PT  - JOURNAL ARTICLE
AU  - D. C. Jung
AU  - H. J. Choi
AU  - W. Ju
AU  - S. C. Kim
AU  - K-G. Choi
TI  - Discordant MRI/FDG- PET imaging for the diagnosis of borderline ovarian tumors
AID  - 10.1136/ijgc-00009577-200807000-00006
DP  - 2008 Jul 01
TA  - International Journal of Gynecologic Cancer
PG  - 637--641
VI  - 18
IP  - 4
4099  - http://ijgc.bmj.com/content/18/4/637.short
4100  - http://ijgc.bmj.com/content/18/4/637.full
SO  - Int J Gynecol Cancer2008 Jul 01; 18
AB  - The objective of this study was to assess the role of 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) for the characterization of ovarian masses that were diagnosed as ovarian malignancies by magnetic resonance imaging (MRI). We performed a retrospective review of eight patients with pathologically confirmed borderline ovarian tumors (BOT) who underwent MRI and FDG-PET before surgical staging from August 2005 to March 2007. We assessed the PET imaging of the BOT, measured the FDG uptake and quantified the findings as a standardized uptake value (SUV). The FDG-PET scans, of all eight patients, showed uptake of FDG with a mean SUV of less than 2.0 in the solid portion of the masses evaluated. We conclude that the MRI–PET differences may help differentiate borderline from malignant ovarian tumors.